Vanguard Group’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$158M Buy
10,985,240
+188,590
+2% +$2.71M ﹤0.01% 1624
2025
Q1
$156M Sell
10,796,650
-15,961
-0.1% -$231K ﹤0.01% 1581
2024
Q4
$142M Buy
10,812,611
+113,976
+1% +$1.5M ﹤0.01% 1700
2024
Q3
$124M Buy
10,698,635
+144,224
+1% +$1.67M ﹤0.01% 1773
2024
Q2
$79.7M Sell
10,554,411
-3,161
-0% -$23.9K ﹤0.01% 1945
2024
Q1
$106M Buy
10,557,572
+164,333
+2% +$1.65M ﹤0.01% 1834
2023
Q4
$96.7M Buy
10,393,239
+23,115
+0.2% +$215K ﹤0.01% 1879
2023
Q3
$132M Buy
10,370,124
+23,111
+0.2% +$294K ﹤0.01% 1655
2023
Q2
$147M Buy
10,347,013
+400,379
+4% +$5.69M ﹤0.01% 1640
2023
Q1
$148M Buy
9,946,634
+208,617
+2% +$3.11M ﹤0.01% 1614
2022
Q4
$145M Buy
9,738,017
+71,723
+0.7% +$1.07M ﹤0.01% 1611
2022
Q3
$160M Sell
9,666,294
-633,464
-6% -$10.5M ﹤0.01% 1522
2022
Q2
$216M Buy
10,299,758
+757,794
+8% +$15.9M 0.01% 1373
2022
Q1
$224M Buy
9,541,964
+212,150
+2% +$4.98M 0.01% 1484
2021
Q4
$254M Buy
9,329,814
+99,111
+1% +$2.7M 0.01% 1457
2021
Q3
$262M Buy
9,230,703
+16,162
+0.2% +$459K 0.01% 1424
2021
Q2
$278M Buy
9,214,541
+212,757
+2% +$6.41M 0.01% 1418
2021
Q1
$229M Buy
9,001,784
+83,416
+0.9% +$2.12M 0.01% 1515
2020
Q4
$219M Buy
8,918,368
+866,790
+11% +$21.3M 0.01% 1413
2020
Q3
$131M Buy
8,051,578
+22,363
+0.3% +$364K ﹤0.01% 1541
2020
Q2
$137M Buy
8,029,215
+105,875
+1% +$1.81M ﹤0.01% 1504
2020
Q1
$92.2M Buy
7,923,340
+430,282
+6% +$5.01M ﹤0.01% 1571
2019
Q4
$208M Sell
7,493,058
-31,898
-0.4% -$886K 0.01% 1362
2019
Q3
$170M Sell
7,524,956
-375,019
-5% -$8.48M 0.01% 1426
2019
Q2
$199M Sell
7,899,975
-5,065
-0.1% -$128K 0.01% 1358
2019
Q1
$215M Sell
7,905,040
-13,243
-0.2% -$360K 0.01% 1290
2018
Q4
$261M Sell
7,918,283
-364,272
-4% -$12M 0.01% 1075
2018
Q3
$386M Buy
8,282,555
+314,415
+4% +$14.7M 0.02% 940
2018
Q2
$345M Sell
7,968,140
-42,456
-0.5% -$1.84M 0.01% 994
2018
Q1
$446M Buy
8,010,596
+148,419
+2% +$8.26M 0.02% 806
2017
Q4
$420M Buy
7,862,177
+79,276
+1% +$4.24M 0.02% 829
2017
Q3
$336M Buy
7,782,901
+231,771
+3% +$9.99M 0.02% 940
2017
Q2
$456M Buy
7,551,130
+38,645
+0.5% +$2.33M 0.02% 742
2017
Q1
$521M Buy
7,512,485
+339,932
+5% +$23.6M 0.03% 678
2016
Q4
$478M Buy
7,172,553
+208,860
+3% +$13.9M 0.03% 673
2016
Q3
$461M Buy
6,963,693
+89,798
+1% +$5.95M 0.03% 651
2016
Q2
$498M Buy
6,873,895
+38,874
+0.6% +$2.82M 0.03% 612
2016
Q1
$442M Buy
6,835,021
+166,219
+2% +$10.7M 0.03% 647
2015
Q4
$478M Buy
6,668,802
+176,256
+3% +$12.6M 0.03% 599
2015
Q3
$499M Buy
6,492,546
+82,332
+1% +$6.32M 0.04% 559
2015
Q2
$475M Buy
6,410,214
+85,858
+1% +$6.36M 0.03% 610
2015
Q1
$459M Buy
6,324,356
+70,584
+1% +$5.12M 0.03% 626
2014
Q4
$413M Buy
6,253,772
+148,469
+2% +$9.82M 0.03% 626
2014
Q3
$335M Buy
6,105,303
+87,546
+1% +$4.8M 0.03% 690
2014
Q2
$350M Sell
6,017,757
-107,090
-2% -$6.23M 0.03% 672
2014
Q1
$380M Buy
6,124,847
+214,535
+4% +$13.3M 0.03% 601
2013
Q4
$315M Buy
5,910,312
+203,150
+4% +$10.8M 0.03% 661
2013
Q3
$287M Buy
5,707,162
+226,696
+4% +$11.4M 0.03% 657
2013
Q2
$251M Buy
+5,480,466
New +$251M 0.03% 676